- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05678699
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
The goal of this study is to learn about the effects of structural inventions, such as equity-focused Medicaid polices, on severe maternal morbidity (SMM) and mortality and maternal health. The main questions it aims to answer are:
- What is the effect of Medicaid healthcare quality interventions on SMM?
- What is the effect of Medicaid healthcare quality interventions + doula care?
- What are Medicaid beneficiaries' experiences in receiving services and the potential impact of integration of doula services and equity practices?
Participants will be asked to describe experiences as a result of structural interventions and focused Medicaid policies.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15261
- Recruiting
- University of Pittsburgh School of Public Health
-
Contact:
- Marquita Smalls, MPH
- Phone Number: 4123830574
- Email: mns69@pitt.edu
-
Principal Investigator:
- Dara D Mendez, PhD
-
Sub-Investigator:
- Marian P Jarlenski, PhD
-
Contact:
- Dara D Mendez, PhD
- Phone Number: 4126485664
- Email: ddm11@pitt.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant and postpartum Medicaid beneficiaries across the US
Qualitative:
- Medicaid beneficiaries who self-identify as Black and/or live in PA Health Equity Zones
- Doulas who provide care to Medicaid beneficiaries in Pennsylvania
- Medicaid Managed Care Organization (MCO) administrators in Pennsylvania. Severe maternal morbidity and mortality outcomes will be assessed in healthcare records and for these quantitative outcomes, patients will not be recruited individually
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard Care
|
|
|
Other: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment) Only
The investigators will employ a quasi-experimental study design to test two hypotheses: H1: SMM rates among Black people will decline after the interventions (equity payment and obstetric bundled payment), relative to people of other race groups within Pennsylvania (PA); and H2: Racial inequities in SMM will decline among those exposed to the interventions in PA, relative to those in similar states.
The investigators will collect qualitative data to assess the effects of the Medicaid healthcare interventions on beneficiaries' experiences.
|
Behavioral: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment)
This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2. 1) health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries
Participants receive standard care without quality interventions or doula care
|
|
Other: Doula Only
The investigators will test two hypotheses: H1: SMM rates among Black people will decline more after the addition of doula care in PA, relative to healthcare quality interventions alone.
H2: Racial inequities in SMM will decline more among those exposed to both healthcare quality and doula care interventions in PA, relative to states implementing doula care only.
The investigators will collect qualitative data to assess the effects of the Medicaid healthcare and service interventions on beneficiaries' experiences.
|
Participants receive standard care without quality interventions or doula care
This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.
|
|
Other: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment) + Doula
|
Behavioral: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment)
This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2. 1) health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries
Participants receive standard care without quality interventions or doula care
This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severe maternal morbidity (SMM)
Time Frame: 20 weeks gestation through 42 days postpartum
|
SMM rate based on the Centers for Disease Control algorithm
|
20 weeks gestation through 42 days postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
All cause mortality
Time Frame: Delivery date through one year after delivery
|
Binary indicator of mortality based on Social Security Administration records
|
Delivery date through one year after delivery
|
|
Follow up for chronic conditions
Time Frame: 43 days through 1 year after delivery
|
Percent of persons who receive guideline concordant care for depression, substance use disorders, immunizations, and screening and referral for social determinants of health
|
43 days through 1 year after delivery
|
|
Provision of evidence care in pregnancy and postpartum
Time Frame: During pregnancy and postpartum up to 1 year
|
Percent of Medicaid patients among each provider who receive screening and follow up for depression, treatment for substance use disorders, perinatal immunizations, and screening and referral for social determinants of health
|
During pregnancy and postpartum up to 1 year
|
|
Medicaid managed care administrator perspectives on policy interventions
Time Frame: Year 3
|
Qualitative self report of perspectives
|
Year 3
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the changes in effects of the Medicaid healthcare quality interventions on beneficiaries' experiences
Time Frame: Years 2, 3, and 4
|
The investigators will collect qualitative data from three different study populations across Pennsylvania who will be affected by the Medicaid policies under study: 1) Medicaid beneficiaries (n=100; Years 2 and 4); 2) Doula care providers (n=60; Years 2 and 4); Managed Care Organization (MCO) leadership (n=10); Year 3
|
Years 2, 3, and 4
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY22080184
- 1R01NR020670-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maternal Death
-
University of OttawaJimma University; Ethiopian Ministry of Health, Jimma ZoneCompletedMaternal Mortality | Maternal Morbidity
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingMaternal Mortality | Perinatal Mortality | Neonatal Mortality | Maternal and Perinatal Death Surveillance and Response (MPDSR) Implementation
-
University of CalgaryCanadian International Development AgencyCompletedChild Mortality | Maternal Mortality (All Cause)Uganda
-
University of CopenhagenMerck Sharp & Dohme LLCCompletedMaternal Mortality | Perinatal MortalityDenmark
-
Michigan State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMaternal Mortality Disparities | Maternal Morbidity DisparitiesUnited States
-
Abdul Latif Jameel Poverty Action LabMacArthur Foundation; Planned Parenthood Federation NigeriaCompletedMaternal MortalityNigeria
-
Society for Applied StudiesWorld Health OrganizationCompletedStill Births | Neonatal Deaths | Maternal DeathsIndia
-
Jimma UniversityRecruitingMaternal Behavior | Maternal DeathEthiopia
-
Express CollaborativeUnknownMaternal Death During ChildbirthCanada
-
Hawassa UniversityUniversidad Pública de NavarraRecruiting